Osteopontin Expression and Its Role in Endometrial Cancer: A Systematic Review
Cancers · 04.07.2025 · 17 (13) · 2245
DOI: 10.3390/cancers17132245 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 04.07.2025. Verfasst von Carmen Imma Aquino und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gynecology and Obstetrics Unit, Department of Translational Medicine, Università del Piemonte Orientale, 28100 Novara, Italy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Osteopontin (OPN) is a 34 kDa protein that is extensively phosphorylated and rich in aspartic acid, produced by a single-copy gene, and altered by post-translational processes. In several diseases, OPN has been discovered to play a direct role in immunological and inflammatory responses. It is also important in kidney stone disease, preeclampsia, cardiovascular disease, endometriosis, and cancer, among other pathological conditions. It is a crucial extracellular matrix molecule involved in oncology, due to its ability to bridge the gap between inflammation and carcinogenesis.
Methods
Our systematic review has as PICO “Does Osteopontin have possible etiological and prognostic correlations in patients affected by endometrial carcinoma?” Based on online data collected from PubMed, Scholar, Embase, Scopus, and other sources, a preliminary analysis was conducted. A keyword search for “Osteopontin” AND “tumors”, “endometrial cancer”, and other related terms was used to identify the publications. The relevance of scientific research was used to select articles in English.
Results
For our systematic review, the citation search yielded nine articles on the topic. At the endometrial level, OPN plays a role in a variety of biological processes, including angiogenesis, metastasis, altered tissue remodeling, immunological responses, cell adhesion, and migration.
Conclusions
With established direct correlations and a potential role in the assessment of the diagnosis and prognosis of the disease, OPN participates in endometrial cancer, drawing more and more attention from researchers.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gynecology and Obstetrics Unit, Department of Translational Medicine, Università del Piemonte Orientale, 28100 Novara, Italy.
- Laboratory of Physiology, Department of Translational Medicine, Università del Piemonte Orientale, 28100 Novara, Italy.
- Department of Obstetrics and Gynecology, "Valle D'Itria" Hospital, Martina Franca, 74015 Taranto, Italy.
ORCID-Profile: Carmen Imma Aquino, Sakthipriyan Venkatesan, Raffaele Tinelli, Elena Grossini, Daniela Surico
Zitieren
APA
Aquino, C. I., Venkatesan, S., Ligori, A., Tinelli, R., Grossini, E., & Surico, D. (2025). Osteopontin Expression and Its Role in Endometrial Cancer: A Systematic Review. Cancers, 17(13), 2245. https://doi.org/10.3390/cancers17132245
Vancouver
Aquino CI, Venkatesan S, Ligori A, Tinelli R, Grossini E, Surico D. Osteopontin Expression and Its Role in Endometrial Cancer: A Systematic Review. Cancers. 2025;17(13):2245. doi:10.3390/cancers17132245
BibTeX
@article{Aquino2025,
author = {Aquino, Carmen Imma and Venkatesan, Sakthipriyan and Ligori, Arianna and Tinelli, Raffaele and Grossini, Elena and Surico, Daniela},
title = {Osteopontin Expression and Its Role in Endometrial Cancer: A Systematic Review},
journal = {Cancers},
year = {2025},
volume = {17},
number = {13},
pages = {2245},
doi = {10.3390/cancers17132245}
}
EUVIMED